Denglong Cheng

Denglong Cheng

Auto-generated profile, based on publicly available information

Denglong Cheng

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in Cancer Research
Verified
Journal Article
Open access
SDShenghe Deng
Shenghe Deng
JWJun Wang
Jun Wang
FZFalong Zou
Falong Zou
DCDenglong Cheng
Denglong Cheng
MCMian Chen
Mian Chen
KCKailin Cai
Kailin Cai
Obstructions can occur during any stage of colorectal cancer and correspond with poor prognosis. Obstructive colorectal cancer (OCRC) is harder and exhibits increased tumor budding and proliferation of myofibroblasts compared with nonobstructive colorectal cancer, suggesting that the occurrence of obstruction may be related to extracellular matrix (ECM) remodeling. In this study, we found that colorectal cancer and OCRC samples differed substantially in ECM composition, specifically in collagen (newly formed and mature) and proteoglycans (including glycosaminoglycan, hyaluronic acid, and chondroitin sulfate). OCRC also exhibited considerable changes in ECM biomechanics and collagen arrangement. Interestingly, OCRC samples presented a notable increase in matrix cancer-associated fibroblasts (mCAF). The abundance of mCAFs correlated with the accumulation of palmitic acid (PA), and high concentrations of PA increased the secretion of ECM-related proteins by mCAFs. Additionally, PA did not directly affect normal fibroblasts but rather activated the NF-κB pathway in tumor cells to stimulate secretion of CSF1, TGFβ1, and CXCL8, which promoted the activation of normal fibroblasts into mCAFs and exacerbated ECM stiffening. Drug screening with a natural compound library identified vanillylacetone as a potential inhibitor of PA-induced cytokine secretion and ECM stiffening. These findings highlight intratumoral PA accumulation as a key mechanism driving ECM alterations and OCRC progression and suggest that targeting this axis may be useful for treating patients with colorectal cancer with risk of obstruction. Significance: Palmitic acid accumulation activates the NF-κB pathway in colorectal cancer cells to promote cytokine secretion that facilitates the generation of matrix cancer-associated fibroblasts, driving extracellular matrix remodeling and development of obstructions.

17 June 2026
Verified
Other
Open access
SDShenghe Deng
Shenghe Deng
JWJun Wang
Jun Wang
FZFalong Zou
Falong Zou
DCDenglong Cheng
Denglong Cheng
MCMian Chen
Mian Chen
KCKailin Cai
Kailin Cai
Figure S13: Dietary PA intervention promoted CAF activation, enhancing ECM stiffness and tumor proliferation. (A) Effects of PA-enriched high-fat diet on the growth of subcutaneous tumors of C57BL/6 (n = 20) and BALB/c mice (n = 10), and orthotopic tumors in Apcmin/+ mice (n = 8). (B-C) Analysis of lipid deposition, collagen fiber content, CAFs abundance, and ECM biomechanical properties in subcutaneous tumor of BALB/c (B) mice and orthotopic tumor of Apcmin/+ (C) mice (Scale bars = 1mm and 50μm; AFM 10μm). (D) Quantification of PA content in subcutaneous tumor and orthotopic tumor of mice. (E) Comparison of ECM biomechanical properties in subcutaneous and orthotopic tumors from mice fed with a PA-enriched versus a normal diet. Statistical significance was determined by unpaired Student t test and two-way ANOVA. **P < 0.01, ***P < 0.001, ****P < 0.0001.

17 June 2026
Verified
Other
Open access
PDF file
SDShenghe Deng
Shenghe Deng
JWJun Wang
Jun Wang
FZFalong Zou
Falong Zou
DCDenglong Cheng
Denglong Cheng
MCMian Chen
Mian Chen
KCKailin Cai
Kailin Cai
Figure S17: Animal models validated vanillylacetone inhibited PA-induced cytokine secretion and NF-to-CAF/mCAF activation. (A-B) Measurement of CSF-1, CXCL8, and TGF-β1 levels in CRC subcutaneous tumors and serum of C57BL/6 (A) and BALB/c (B) mice post-vanillylacetone treatment. (C) Immunofluorescence staining analysis of mCAFs in BALB/c mice subcutaneous tumors post-vanillylacetone treatment, green: FN1, red: α-SMA (Scale bars = 1mm and 20μm). (D) FN1-positive CAFs content in subcutaneous tumors from C57BL/6 and BALB/c mice post-vanillylacetone treatment. Statistical significance was determined by unpaired Student t test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, no significance.

17 June 2026
Verified
Other
Open access
SDShenghe Deng
Shenghe Deng
JWJun Wang
Jun Wang
FZFalong Zou
Falong Zou
DCDenglong Cheng
Denglong Cheng
MCMian Chen
Mian Chen
KCKailin Cai
Kailin Cai
Figure S4: Functional analyses on α-SMA-positive CAFs and NFs from OCRC, CRC, and normal tissues. (A) KEGG and GO enrichment analysis of α-SMA positive cells from OCRC and CRC tissues. (B) KEGG and GO enrichment analysis of α-SMA positive cells from OCRC and Normal tissues. (C) KEGG and GO enrichment analysis of α-SMA positive cells from CRC and Normal tissues.

17 June 2026
Verified
Other
Open access
PDF file
SDShenghe Deng
Shenghe Deng
JWJun Wang
Jun Wang
FZFalong Zou
Falong Zou
DCDenglong Cheng
Denglong Cheng
MCMian Chen
Mian Chen
KCKailin Cai
Kailin Cai
Figure S1: OCRC and CRC differed substantially in clinicopathology, with poorer prognoses in OCRC. (A) Comparative analysis of OS and DFS in CRC (n=1272) and OCRC (n=198) patients. (B) Clinicopathological characteristics of CRC (n=1272) and OCRC (n=198) patients. (C) Comparative analysis of OS and DFS in 150 matched pairs of CRC and OCRC patients. (D) Clinicopathological characteristics of 150 matched pairs of OCRC and CRC. Statistical significance was determined by Chi-Squared Test. *P <0.05, **P <0.01, ***P <0.001.

17 June 2026
Verified
Other
Open access
SDShenghe Deng
Shenghe Deng
JWJun Wang
Jun Wang
FZFalong Zou
Falong Zou
DCDenglong Cheng
Denglong Cheng
MCMian Chen
Mian Chen
KCKailin Cai
Kailin Cai
Nontargeted metabolomics analysis of OCRC and CRC tissues